🔎 Trials Near Me

Hem › Myeloproliferativa neoplasmer › South Carolina

Kliniska studier för Myeloproliferativa neoplasmer i South Carolina

5 studier för Myeloproliferativa neoplasmer söker deltagare vid platser i South Carolina.

Städer i South Carolina

Officiell studietext (engelska)

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

  • Prisma Health Cancer Institute - Spartanburg, Boiling Springs
  • Medical University of South Carolina, Charleston
  • Prisma Health Cancer Institute - Easley, Easley
  • och 5 fler
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 5 okt. 2026 · NCT05564390

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

  • Prisma Health Cancer Institute - Spartanburg, Boiling Springs
  • Medical University of South Carolina, Charleston
  • Prisma Health Cancer Institute - Easley, Easley
  • och 5 fler
RekryterarFas 2
Ålder 18 till 59 · Alla kön · Uppdaterad 22 sep. 2026 · NCT05554406

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

  • MUSC Health University Medical Center, Charleston
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 15 sep. 2026 · NCT04996875

Project: Every Child for Younger Patients With Cancer

  • Medical University of South Carolina, Charleston
  • Prisma Health Richland Hospital, Columbia
  • BI-LO Charities Children's Cancer Center, Greenville
  • och 2 fler
RekryterarObservationsstudie
Upp till ålder 25 · Alla kön · Uppdaterad 25 aug. 2026 · NCT02402244

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Greenville
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 28 okt. 2025 · NCT03452774

Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.